New Treatment for Bladder Cancer Offers This Biotech a Second Chance
Wall Street Journal
UroGen hopes to have success with a new treatment after its first drug was a commercial flop.
Understanding current events through the lenses of the past and future.
Wall Street Journal
UroGen hopes to have success with a new treatment after its first drug was a commercial flop.